Tandem Diabetes Care Inc. (NASDAQ: TNDM) received CE mark approval to expand use of its automated insulin delivery systems in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE